Literature DB >> 7295546

Emblica officinalis Gaertn and serum cholesterol level in experimental rabbits.

M Mishra, U N Pathak, A B Khan.   

Abstract

Twelve albino rabbits of either sex weighing 1.0-1.25 kg were fed a standard laboratory diet of green grass and sattu (roasted Bengal gram). After a 2-week run-in period their serum cholesterol levels were estimated. All animals were now fed 0.5 g cholesterol and 1.0 g clarified butter daily and were not divided into 3 groups of 4 animals each. While all received the standard cholesterol-rich diet, Group A animals received no additional substances, animals in Group B were each fed 10 mg vitamin C daily, while those in Group C were each given 1.0 g fresh Amla (Emblica officinalis Gaertn). Mean serum cholesterol levels in all three groups rose to significantly higher levels by the end of the second week. There was a further rise by the end of the third and fourth weeks in Groups A and B. However, animals in Group C (i.e. those given Amla) showed significantly lower mean serum cholesterol levels at the end of the second week than their counterparts in Groups A and B. At the end of the third and fourth weeks the differences were even more pronounced.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295546      PMCID: PMC2041704     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  3 in total

1.  A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia.

Authors:  B Antony; M Benny; T N B Kaimal
Journal:  Indian J Clin Biochem       Date:  2008-12-20

Review 2.  Immunomodulatory effects of triphala and its individual constituents: a review.

Authors:  Pranoti Belapurkar; Pragya Goyal; Preeti Tiwari-Barua
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

3.  Amlamax in the management of dyslipidemia in humans.

Authors:  B Antony; B Merina; V Sheeba
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.